Aspivix Cervical Stabilizer Reduces Pain and Bleeding

Pain and bleeding were reduced in a clinical trial testing Aspivix’s Carevix cervical stabilizer device against a standard tenaculum — used to stabilize the cervix to ease passage of instruments — among women undergoing intrauterine device (IUD) placement to prevent pregnancy.

Carevix uses suction to stabilize the cervix instead of potentially perforating it with the tenaculum, reducing pain and bleeding, the company said.

Researchers at the University Hospitals of Geneva and the University Hospital of Lausanne in Switzerland studied 100 women undergoing IUD placement with 48 assigned to Carevix and 52 assigned to the current standard of care, the cervical tenaculum.

Compared to the tenaculum study group, the Carevix patients had a 30 to 53 percent reduction in pain scores and a 78 percent reduction in cervical bleeding from the procedure. Women who had not experienced a live birth reported far less severe pain than women who had given birth.